EcoDrugPlus

Ensembl ID : YDR456W
Description: -
178 Possible Orthologues:

Title

Ensembl ID : YDR471W
Description: -
80 Possible Orthologues:

Title

Ensembl ID : YDR490C
Description: -
74 Possible Orthologues:

Title

Ensembl ID : YDR516C
Description: -
77 Possible Orthologues:

Title

Ensembl ID : YEL016C
Description: -
185 Possible Orthologues:

Title

Ensembl ID : YEL054C
Description: -
104 Possible Orthologues:

Title

Ensembl ID : YEL061C
Description: -
91 Possible Orthologues:

Title

Ensembl ID : YER012W
Description: -
76 Possible Orthologues:

Title

Ensembl ID : YER021W
Description: -
136 Possible Orthologues:

Title

Ensembl ID : YER074W
Description: -
91 Possible Orthologues:

Title

Ensembl ID : YER094C
Description: -
73 Possible Orthologues:

Title

Ensembl ID : YER101C
Description: -
1593 Possible Orthologues:

Title

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).